Is OTIC stock a buy right now?
2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Otonomy in the last twelve months. There are currently 2 buy rati...
Will Otonomy's stock price go up in 2022?
2 brokerages have issued 12 month price objectives for Otonomy's shares. Their forecasts range from $6.00 to $6.00. On average, they expect Otonomy...
How has Otonomy's stock price performed in 2022?
Otonomy's stock was trading at $2.08 at the start of the year. Since then, OTIC stock has decreased by 3.4% and is now trading at $2.01. View the...
When is Otonomy's next earnings date?
Otonomy is scheduled to release its next quarterly earnings announcement on Wednesday, August 3rd 2022. View our earnings forecast for Otonomy .
How were Otonomy's earnings last quarter?
Otonomy, Inc. (NASDAQ:OTIC) announced its earnings results on Monday, May, 9th. The biopharmaceutical company reported ($0.20) EPS for the quarter,...
Who are Otonomy's key executives?
Otonomy's management team includes the following people: Dr. David Allen Weber , Pres, CEO & Director (Age 62, Pay $907.68k) Mr. Paul E. Cayer ,...
Who are some of Otonomy's key competitors?
Some companies that are related to Otonomy include Janux Therapeutics (JANX) , Bicycle Therapeutics (BCYC) , Protagonist Therapeutics (PTGX) ,...
What other stocks do shareholders of Otonomy own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Otonomy investors own include BMO Capital Markets () , St...
What is Otonomy's stock symbol?
Otonomy trades on the NASDAQ under the ticker symbol "OTIC."
About Otonomy
Otonomy, Inc. operates as a biopharmaceutical company. It engages in the development of therapeutics for neurotology.
Otonomy (NASDAQ:OTIC) Frequently Asked Questions
2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Otonomy in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Otonomy stock. View analyst ratings for Otonomy or view top-rated stocks.
Ideas
NASDAQ:OTIC Possible Scenario: LONG Evidence: Price Action, Bullish candlestick TP1 ~6.5$ * 20% Profit This is my idea and could be wrong 100%
Profile
Otonomy, Inc. operates as a biopharmaceutical company. It engages in the development of therapeutics for neurotology.
